APE1/Ref-1 regulates PTEN expression mediated by Egr-1

Free Radical Research

Volumn 42, Issue 1, 2008, Pages 20-29

  Fantini, Damiano ^a   Vascotto, Carlo ^a   Deganuto, Marta ^a   Bivi, Nicoletta ^a   Gustincich, Stefano ^b   Marcon, Gabriella ^a   Quadrifoglio, Franco ^a   Damante, Giuseppe ^a   Bhakat, Kishor K ^c   Mitra, Sankar ^c   Tell, Gianluca ^a  

^a UNIVERSITY OF UDINE   (Italy)

^b SISSA   (Italy)

^c University of Texas Medical Branch School of Medicine   (United States)

Author keywords

APE1 Ref 1; Egr 1; Histone acetyltransferase inhibitors; Oxidative stress response; PTEN; siRNA

Indexed keywords

EARLY GROWTH RESPONSE FACTOR 1; HISTONE DEACETYLASE; HISTONE DEACETYLASE INHIBITOR; HYDROGEN PEROXIDE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; REDOX EFFECTOR FACTOR 1; TRANS ACTING FACTOR;

ACETYLATION; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DEACETYLATION; DOWN REGULATION; GENE ACTIVATION; GENE REPRESSION; HELA CELL; HUMAN; HUMAN CELL; IN VIVO STUDY; OXIDATIVE STRESS; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; REGULATORY MECHANISM; STRESS;

ACETYLATION; BUTYRATES; CELL NUCLEUS; DNA-(APURINIC OR APYRIMIDINIC SITE) LYASE; EARLY GROWTH RESPONSE PROTEIN 1; ENZYME INHIBITORS; HCT116 CELLS; HELA CELLS; HISTONE DEACETYLASES; HUMANS; HYDROGEN PEROXIDE; HYDROXAMIC ACIDS; OXIDATIVE STRESS; PROMOTER REGIONS (GENETICS); PTEN PHOSPHOHYDROLASE; RNA INTERFERENCE; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TIME FACTORS; TRANSFECTION; TUMOR SUPPRESSOR PROTEIN P53; UP-REGULATION;

MAMMALIA;

EID: 40649115277     PISSN: 10715762     EISSN: 10292470     Source Type: Journal    
DOI: 10.1080/10715760701765616     Document Type: Article

References (46)

1. Tell, G., Damante, G., Caldwell, D. and Kelley, MR. (2005) The intracellular localization of APE1/Ref-1: More than a passive phenomenon?. Antioxid Redox Signal, 7, pp. 367-384.
2. Mitra, S., Izumi, T., Boldogh, I., Bhakat, KK, Chattopadhyay, R. and Szczesny, B. (2007) Intracellular trafficking and regulation of mammalian AP-endonuclease 1 (APE1), an essential DNA repair protein. DNA Repair (Amst), 6, pp. 461-469.
3. Robertson, KA, Hill, DP, Xu, Y., Liu, L., Van Epps, S., Hockenbery, DM, Park, JR, Wilson, TM and Kelley, MR. (1997) Down-regulation of apurinic/ apyrimidinic endonuclease expression is associated with the induction of apoptosis in differentiating myeloid leukemia cells. Cell Growth Differ, 8, pp. 443-449.
4. Fung, H. and Demple, B. (2005) A vital role for Ape1/Ref1 protein in repairing spontaneous DNA damage in human cells. Mol Cell, 17, pp. 463-470.
5. Ramana, CV, Boldogh, I., Izumi, T. and Mitra, S. (1998) Activation of apurinic/apyrimidinic endonuclease in human cells by reactive oxygen species and its correlation with their adaptive response to genotoxicity of free radicals. Proc Natl Acad Sci USA, 95, pp. 5061-5066.
6. Bhakat, KK, Izumi, T., Yang, SH, Hazra, TK and Mitra, S. (2003) Role of acetylated human AP-endonuclease (APE1/Ref-1) in regulation of the parathyroid hormone gene. EMBO J, 22, pp. 6299-6309.
7. Finkel, T. (2003) Oxidant signals and oxidative stress. Curr Opin Cell Biol, 15, pp. 247-254.
8. Gaiddon, C., Moorthy, NC and Prives, C. (1999) Ref-1 regulates the transactivation and pro-apoptotic functions of p53 in vivo. EMBO J, 18, pp. 5609-5621.
9. Xanthoudakis, S. and Curran, T. (1992) Identification and characterization of Ref-1, a nuclear protein that facilitates AP-1 DNA-binding activity. EMBO J, 11, pp. 653-665.
10. Huang, RP and Adamson, ED. (1993) Characterization of the DNA binding properties of the early growth response-1 (Egr-1) transcription factor: evidence for modulation by a redox mechanism. DNA Cell Biol, 12, pp. 265-273.
11. Pines, A., Bivi, N., Romanello, M., Damante, G., Kelley, MR, Adamson, ED, D'Andrea, P., Quadrifoglio, F., Moro, L. and Tell, G. (2005) Cross-regulation between Egr-1 and APE/Ref-1 during early response to oxidative stress in the human osteoblastic HOBIT cell line: Evidence for an autoregulatory loop. Free Radic Res, 39, pp. 269-281.
12. Huang, RP, Wu, JX, Fan, Y. and Adamson, ED. (1996) UV activates growth factor receptors via reactive oxygen intermediates. J Cell Biol, 133, pp. 211-220.
13. Liu, C., Rangnekar, VM, Adamson, E. and Mercola, D. (1998) Suppression of growth and transformation and induction of apoptosis by EGR-1. Cancer Gene Ther, 5, pp. 3-28.
14. Huang, RP, Fan, Y., de Belle, I., Niemeyer, C., Gottardis, MM, Mercola, D. and Adamson, ED. (1997) Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumour formation. Int J Cancer, 72, pp. 102-109.
15. Krones-Herzig, A., Mittal, S., Yule, K., Liang, H., English, C., Urcis, R., Soni, T., Adamson, ED and Mercola, D. (2005) Early growth response 1 acts as a tumor suppressor in vivo and in vitro via regulation of p53. Cancer Res, 65, pp. 5133-5143.
16. Virolle, T., Adamson, ED, Baron, V., Birle, D., Mercola, D., Mustelin, T. and de Belle, I. (2001) The Egr-1 transcription factor directly activates PTEN during irradiation-induced signalling. Nat Cell Biol, 3, pp. 1124-1128.
17. Baron, V., Adamson, ED, Calogero, A., Ragona, G. and Mercola, D. (2006) The transcription factor Egr1 is a direct regulator of multiple tumor suppressors including TGFbeta1, PTEN, p53, and fibronectin. Cancer Gene Ther, 13, pp. 115-124.
18. Sansal, I. and Sellers, WR. (2004) The biology and clinical relevance of the PTEN tumor suppressor pathway. J Clin Oncol, 22, pp. 2954-2963.
19. Tell, G., Pines, A., Arturi, F., Cesaratto, L., Adamson, E., Puppin, C., Presta, I., Russo, D., Filetti, S. and Damante, G. (2004) Control of phosphatase and tensin homolog (PTEN) gene expression in normal and neoplastic thyroid cells. Endocrinology, 145, pp. 4660-4666.
20. Pines, A., Perrone, L., Bivi, N., Romanello, M., Damante, G., Gulisano, M., Kelley, MR, Quadrifoglio, F. and Tell, G. (2005) Activation of APE1/ Ref-1 is dependent on reactive oxygen species generated after purinergic receptor stimulation by ATP. Nucleic Acids Res, 33, pp. 4379-4394.
21. Izumi, T., Brown, DB, Naidu, CV, Bhakat, KK, Macinnes, MA, Saito, H., Chen, DJ and Mitra, S. (2005) Two essential but distinct functions of the mammalian abasic endonuclease. Proc Natl Acad Sci USA, 102, pp. 5739-5743.
22. Grunstein, M. (1997) Histone acetylation in chromatin structure and transcription. Nature, 389, pp. 349-352.
23. Kuo, MH and Allis, CD. (1998) Roles of histone acetyltransferases and deacetylases in gene regulation. Bioessays, 20, pp. 615-626.
24. Katan-Khaykovich, Y. and Struhl, K. (2002) Dynamics of global histone acetylation and deacetylation in vivo: Rapid restoration of normal histone acetylation status upon removal of activators and repressors. Genes Dev, 16, pp. 743-752.
25. Davie, JR. (2003) Inhibition of histone deacetylase activity by butyrate. J Nutr, 133, pp. 2485S-2493S.
26. Eberharter, A. and Becker, PB. (2002) Histone acetylation: A switch between repressive and permissive chromatin. Second in review series on chromatin dynamics. EMBO Rep, 3, pp. 224-229.
27. Davis, PK and Brackmann, RK. (2003) Chromatin remodeling and cancer. Cancer Biol Ther, 2, pp. 22-29.
28. Lehrmann, H., Pritchard, LL and Harel-Bellan, A. (2002) Histone acetyltransferases and deacetylases in the control of cell proliferation and differentiation. Adv Cancer Res, 86, pp. 41-65.
29. Kim, DH, Kim, M. and Kwon, HJ. (2003) Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents. J Biochem Mol Biol, 36, pp. 110-119.
30. Bunz, F., Dutriaux, A., Lengauer, C., Waldman, T., Zhou, S., Brown, JP, Sedivy, JM, Kinzler, KW and Vogelstein, B. (1998) Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science, 282, pp. 1497-1501.
31. Bradford, MM. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem, 72, pp. 248-254.
32. Szczesny, B., Bhakat, KK, Mitra, S. and Boldogh, I. (2004) Age-dependent modulation of DNA repair enzymes by covalent modification and subcellular distribution. Mech Ageing Dev, 125, pp. 755-765.
33. Huang, RP, Darland, T., Okamura, D., Mercola, D. and Adamson, ED. (1994) Suppression of v-sis-dependent transformation by the transcription factor Egr-1. Oncogene, 9, pp. 1367-1377.
34. Mittal, V. (2004) Improving the efficiency of RNA interference in mammals. Nat Rev Genet, 5, pp. 355-365.
35. van de Wetering, M., Oving, I., Muncan, V., Fong, MT Pon, Brantjes, H., van Leenen, D., Holstege, FC, Brummelkamp, TR, Agami, R. and Clevers, H. (2003) Specific inhibition of gene expression using a stably integrated, inducible small-interfering-RNA vector. EMBO Rep, 4, pp. 609-615.
36. Stambolic, V., MacPherson, D., Sas, D., Lin, Y., Snow, B., Jang, Y., Benchimol, S. and Mak, TW. (2001) Regulation of PTEN transcription by p53. Mol Cell, 8, pp. 317-325.
37. Whelan, JT, Forbes, SL and Bertrand, FE. (2007) CBF-1 (RBP-Jkappa) binds to the PTEN promoter and regulates PTEN gene expression. Cell Cycle, 6, pp. 80-84.
38. Kim, S., Domon-Dell, C., Kang, J., Chung, DH, Freund, JN and Evers, BM. (2004) Down-regulation of the tumor suppressor PTEN by the tumor necrosis factor-alpha/nuclear factor-kappaB (NF-kappaB)-inducing kinase/ NF-kappaB pathway is linked to a default IkappaB-alpha autoregulatory loop. J Biol Chem, 279, pp. 4285-4291.
39. Patel, L., Pass, I., Coxon, P., Downes, CP, Smith, SA and Macphee, CH. (2001) Tumor suppressor and anti-inflammatory actions of PPARgamma agonists are mediated via upregulation of PTEN. Curr Biol, 11, pp. 764-768.
40. Seo, YR, Kelley, MR and Smith, ML. (2002) Selenomethionine regulation of p53 by a ref1-dependent redox mechanism. Proc Natl Acad Sci USA, 99, pp. 14548-14553.
41. Hanson, S., Kim, E. and Deppert, W. (2005) Redox factor 1 (Ref-1) enhances specific DNA binding of p53 by promoting p53 tetramerization. Oncogene, 24, pp. 1641-1647.
42. Leslie, NR, Bennett, D., Lindsay, YE, Stewart, H., Gray, A. and Downes, CP. (2003) Redox regulation of PI 3-kinase signalling via inactivation of PTEN. EMBO J, 22, pp. 5501-5510.
43. Pan, L., Lu, J., Wang, X., Han, L., Zhang, Y., Han, S. and Huang, B. (2007) Histone deacetylase inhibitor trichostatin a potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. Cancer, 109, pp. 1676-1688.
44. Brugarolas, J., Chandrasekaran, C., Gordon, JI, Beach, D., Jacks, T. and Hannon, GJ. (1995) Radiation-induced cell cycle arrest compromised by p21 deficiency. Nature, 377, pp. 552-557.
45. Okamoto, K. and Prives, C. (1999) A role of cyclin G in the process of apoptosis. Oncogene, 18, pp. 4606-4615.
46. Bernstein, C., Bernstein, H., Payne, CM and Garewal, H. (2002) DNA repair/pro-apoptotic dual-role proteins in five major DNA repair pathways: Fail-safe protection against carcinogenesis. Mutat Res, 511, pp. 145-178.